Report Detail

Other Global Neurointerventional Device Market Research Report 2021

  • RnM3402204
  • |
  • 15 February, 2021
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Other

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Embolic Coils
Neurovascular Stents (Carotid Stents and Intracranial Stents)
Neurovascular Thrombectomy Devices
Intrasaccular Devices
Embolic Protection Devices
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Codman & Shurtleff
Integra Life Sciences
Medtronic
Stryker
Boston Scientific
BrainLab
Elekta
Karl Storz
Micromar
Scopis
SPR Therapeutics
Abbott
Synapse Biomedical
Aesculap (B. Braun)
TeDan Surgical Innovations
Kogent Surgical


1 Neurointerventional Device Market Overview

  • 1.1 Product Overview and Scope of Neurointerventional Device
  • 1.2 Neurointerventional Device Segment by Type
    • 1.2.1 Global Neurointerventional Device Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Embolic Coils
    • 1.2.3 Neurovascular Stents (Carotid Stents and Intracranial Stents)
    • 1.2.4 Neurovascular Thrombectomy Devices
    • 1.2.5 Intrasaccular Devices
    • 1.2.6 Embolic Protection Devices
    • 1.2.7 Others
  • 1.3 Neurointerventional Device Segment by Application
    • 1.3.1 Neurointerventional Device Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centers
    • 1.3.4 Others
  • 1.4 Global Neurointerventional Device Market Size Estimates and Forecasts
    • 1.4.1 Global Neurointerventional Device Revenue 2016-2027
    • 1.4.2 Global Neurointerventional Device Sales 2016-2027
    • 1.4.3 Neurointerventional Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neurointerventional Device Market Competition by Manufacturers

  • 2.1 Global Neurointerventional Device Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Neurointerventional Device Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Neurointerventional Device Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Neurointerventional Device Manufacturing Sites, Area Served, Product Type
  • 2.5 Neurointerventional Device Market Competitive Situation and Trends
    • 2.5.1 Neurointerventional Device Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Neurointerventional Device Players Market Share by Revenue
    • 2.5.3 Global Neurointerventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neurointerventional Device Retrospective Market Scenario by Region

  • 3.1 Global Neurointerventional Device Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Neurointerventional Device Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Neurointerventional Device Market Facts & Figures by Country
    • 3.3.1 North America Neurointerventional Device Sales by Country
    • 3.3.2 North America Neurointerventional Device Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Neurointerventional Device Market Facts & Figures by Country
    • 3.4.1 Europe Neurointerventional Device Sales by Country
    • 3.4.2 Europe Neurointerventional Device Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Neurointerventional Device Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Neurointerventional Device Sales by Region
    • 3.5.2 Asia Pacific Neurointerventional Device Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Neurointerventional Device Market Facts & Figures by Country
    • 3.6.1 Latin America Neurointerventional Device Sales by Country
    • 3.6.2 Latin America Neurointerventional Device Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Neurointerventional Device Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Neurointerventional Device Sales by Country
    • 3.7.2 Middle East and Africa Neurointerventional Device Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Neurointerventional Device Historic Market Analysis by Type

  • 4.1 Global Neurointerventional Device Sales Market Share by Type (2016-2021)
  • 4.2 Global Neurointerventional Device Revenue Market Share by Type (2016-2021)
  • 4.3 Global Neurointerventional Device Price by Type (2016-2021)

5 Global Neurointerventional Device Historic Market Analysis by Application

  • 5.1 Global Neurointerventional Device Sales Market Share by Application (2016-2021)
  • 5.2 Global Neurointerventional Device Revenue Market Share by Application (2016-2021)
  • 5.3 Global Neurointerventional Device Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Codman & Shurtleff
    • 6.1.1 Codman & Shurtleff Corporation Information
    • 6.1.2 Codman & Shurtleff Description and Business Overview
    • 6.1.3 Codman & Shurtleff Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Codman & Shurtleff Product Portfolio
    • 6.1.5 Codman & Shurtleff Recent Developments/Updates
  • 6.2 Integra Life Sciences
    • 6.2.1 Integra Life Sciences Corporation Information
    • 6.2.2 Integra Life Sciences Description and Business Overview
    • 6.2.3 Integra Life Sciences Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Integra Life Sciences Product Portfolio
    • 6.2.5 Integra Life Sciences Recent Developments/Updates
  • 6.3 Medtronic
    • 6.3.1 Medtronic Corporation Information
    • 6.3.2 Medtronic Description and Business Overview
    • 6.3.3 Medtronic Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Medtronic Product Portfolio
    • 6.3.5 Medtronic Recent Developments/Updates
  • 6.4 Stryker
    • 6.4.1 Stryker Corporation Information
    • 6.4.2 Stryker Description and Business Overview
    • 6.4.3 Stryker Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Stryker Product Portfolio
    • 6.4.5 Stryker Recent Developments/Updates
  • 6.5 Boston Scientific
    • 6.5.1 Boston Scientific Corporation Information
    • 6.5.2 Boston Scientific Description and Business Overview
    • 6.5.3 Boston Scientific Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Boston Scientific Product Portfolio
    • 6.5.5 Boston Scientific Recent Developments/Updates
  • 6.6 BrainLab
    • 6.6.1 BrainLab Corporation Information
    • 6.6.2 BrainLab Description and Business Overview
    • 6.6.3 BrainLab Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 BrainLab Product Portfolio
    • 6.6.5 BrainLab Recent Developments/Updates
  • 6.7 Elekta
    • 6.6.1 Elekta Corporation Information
    • 6.6.2 Elekta Description and Business Overview
    • 6.6.3 Elekta Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Elekta Product Portfolio
    • 6.7.5 Elekta Recent Developments/Updates
  • 6.8 Karl Storz
    • 6.8.1 Karl Storz Corporation Information
    • 6.8.2 Karl Storz Description and Business Overview
    • 6.8.3 Karl Storz Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Karl Storz Product Portfolio
    • 6.8.5 Karl Storz Recent Developments/Updates
  • 6.9 Micromar
    • 6.9.1 Micromar Corporation Information
    • 6.9.2 Micromar Description and Business Overview
    • 6.9.3 Micromar Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Micromar Product Portfolio
    • 6.9.5 Micromar Recent Developments/Updates
  • 6.10 Scopis
    • 6.10.1 Scopis Corporation Information
    • 6.10.2 Scopis Description and Business Overview
    • 6.10.3 Scopis Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Scopis Product Portfolio
    • 6.10.5 Scopis Recent Developments/Updates
  • 6.11 SPR Therapeutics
    • 6.11.1 SPR Therapeutics Corporation Information
    • 6.11.2 SPR Therapeutics Neurointerventional Device Description and Business Overview
    • 6.11.3 SPR Therapeutics Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 SPR Therapeutics Product Portfolio
    • 6.11.5 SPR Therapeutics Recent Developments/Updates
  • 6.12 Abbott
    • 6.12.1 Abbott Corporation Information
    • 6.12.2 Abbott Neurointerventional Device Description and Business Overview
    • 6.12.3 Abbott Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Abbott Product Portfolio
    • 6.12.5 Abbott Recent Developments/Updates
  • 6.13 Synapse Biomedical
    • 6.13.1 Synapse Biomedical Corporation Information
    • 6.13.2 Synapse Biomedical Neurointerventional Device Description and Business Overview
    • 6.13.3 Synapse Biomedical Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Synapse Biomedical Product Portfolio
    • 6.13.5 Synapse Biomedical Recent Developments/Updates
  • 6.14 Aesculap (B. Braun)
    • 6.14.1 Aesculap (B. Braun) Corporation Information
    • 6.14.2 Aesculap (B. Braun) Neurointerventional Device Description and Business Overview
    • 6.14.3 Aesculap (B. Braun) Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Aesculap (B. Braun) Product Portfolio
    • 6.14.5 Aesculap (B. Braun) Recent Developments/Updates
  • 6.15 TeDan Surgical Innovations
    • 6.15.1 TeDan Surgical Innovations Corporation Information
    • 6.15.2 TeDan Surgical Innovations Neurointerventional Device Description and Business Overview
    • 6.15.3 TeDan Surgical Innovations Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 TeDan Surgical Innovations Product Portfolio
    • 6.15.5 TeDan Surgical Innovations Recent Developments/Updates
  • 6.16 Kogent Surgical
    • 6.16.1 Kogent Surgical Corporation Information
    • 6.16.2 Kogent Surgical Neurointerventional Device Description and Business Overview
    • 6.16.3 Kogent Surgical Neurointerventional Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Kogent Surgical Product Portfolio
    • 6.16.5 Kogent Surgical Recent Developments/Updates

7 Neurointerventional Device Manufacturing Cost Analysis

  • 7.1 Neurointerventional Device Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Neurointerventional Device
  • 7.4 Neurointerventional Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Neurointerventional Device Distributors List
  • 8.3 Neurointerventional Device Customers

9 Neurointerventional Device Market Dynamics

  • 9.1 Neurointerventional Device Industry Trends
  • 9.2 Neurointerventional Device Growth Drivers
  • 9.3 Neurointerventional Device Market Challenges
  • 9.4 Neurointerventional Device Market Restraints

10 Global Market Forecast

  • 10.1 Neurointerventional Device Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Neurointerventional Device by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Neurointerventional Device by Type (2022-2027)
  • 10.2 Neurointerventional Device Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Neurointerventional Device by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Neurointerventional Device by Application (2022-2027)
  • 10.3 Neurointerventional Device Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Neurointerventional Device by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Neurointerventional Device by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Neurointerventional Device . Industry analysis & Market Report on Neurointerventional Device is a syndicated market report, published as Global Neurointerventional Device Market Research Report 2021. It is complete Research Study and Industry Analysis of Neurointerventional Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,331.60
    3,497.40
    4,663.20
    2,711.50
    4,067.25
    5,423.00
    448,659.00
    672,988.50
    897,318.00
    241,657.00
    362,485.50
    483,314.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report